McKesson Corporation is an American company distributing pharmaceuticals and providing health information technology, medical supplies, and care management tools.
| Revenue (TTM) | $397.96B |
| Gross Profit (TTM) | $13.74B |
| EBITDA | $5.93B |
| Operating Margin | 1.55% |
| Return on Equity | 0.00% |
| Return on Assets | 4.33% |
| Revenue/Share (TTM) | $3202.88 |
| Book Value | $-10.55 |
| Price-to-Book | 4.92 |
| Price-to-Sales (TTM) | 0.25 |
| EV/Revenue | 0.265 |
| EV/EBITDA | 16.20 |
| Quarterly Earnings Growth (YoY) | 38.00% |
| Quarterly Revenue Growth (YoY) | 11.40% |
| Shares Outstanding | $122.49M |
| Float | $122.33M |
| % Insiders | 0.10% |
| % Institutions | 91.68% |
Volatility is currently contracting